Skip to menu Skip to content Skip to footer

2007

Journal Article

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

Stockler, M. R., O'Connell, R., Nowak, A. K., Goldstein, D., Turner, J., Wilcken, N. R. C., Wyld, D., Abdi, E., Glasgow, A., Beale, P. J., Jefford, M., Dhillon, H., Heritier, S., Carter, C., Hickie, I. B. and Simes, R. J. (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. The Lancet Oncology, 8 (7), 603-612. doi: 10.1016/S1470-2045(07)70148-1

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

2007

Journal Article

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

Friedlander, M, Buck, M, Wyld, D, Findlay, M, Fitzharris, B, De Souza, P, Davies, T, Kalimi, G, Allan, S, Perez, D and Harnett, P (2007). Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer. International Journal of Gynecological Cancer, 17 (2), 350-358. doi: 10.1111/j.1525-1438.2007.00795.x

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

2007

Journal Article

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

Kefford, Richard, Beith, Jane McNeil, Van Hazel, Guy Arthur, Millward, Michael, Trotter, James Marshall, Wyld, David Keith, Kusic, Rada, Shreeniwas, Revati, Morganti, Adele, Ballmer, Andrea, Segal, Eleonor, Nayler, Oliver and Clozel, Martine (2007). A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma. Investigational New Drugs, 25 (3), 247-252. doi: 10.1007/s10637-006-9014-7

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

2006

Journal Article

Metastatic paraganglioma with extensive bone marrow involvement

Morris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x

Metastatic paraganglioma with extensive bone marrow involvement

2004

Journal Article

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer

Le Chevalier, T., Arriagada, R., Le Pechoux, C., Grunenwald, D., Dunant, A., Pignon, J. P., Tarayre, M., Abratt, R., Arriagada, R., Bergman, B., Gralla, R., Grunenwald, D., Le Chevalier, T., Orlowski, T., Papadakis, E., Pinel, M. I. Sathler, Araujo, C., Della Torre, H., de Solchaga, M. Masetto, Abdi, E., Blum, R., Ball, D., Basser, R., De Boer, R., Bishop, J., Brigham, B., Davis, S., Fox, D., Richardson, G. ... Wedel, H. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine, 350 (4), 351-360. doi: 10.1056/NEJMoa031644

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer

2000

Journal Article

Conquering chemotherapy

Horwood, Keith and Wyld, David (2000). Conquering chemotherapy. Australian Prescriber, 23 (3).

Conquering chemotherapy

2000

Journal Article

Conquering chemotherapy [3] (multiple letters)

Allison, R., Horwood, K. and Wyld, D. (2000). Conquering chemotherapy [3] (multiple letters). Australian Prescriber, 23 (3).

Conquering chemotherapy [3] (multiple letters)

2000

Journal Article

Cisplatin-based therapy: A neurological and neurophysical review

Troy, L., McFarland, K. A., Littman-Powers, S., Kelly, B. J., Walpole, E. T., Wyld, D. and Thomson, D. (2000). Cisplatin-based therapy: A neurological and neurophysical review. Psychooncology, 9 (1), 29-39. doi: 10.1002/(SICI)1099-1611(200001/02)9:1

Cisplatin-based therapy: A neurological and neurophysical review

2000

Journal Article

Cisplatin-based therapy: A neurological and neuropsychological review

Troy, L., McFarland, K., Littman-Power, S., Kelly, B.J., Walpole, E.T., Wyld, D. and Thomson, D. (2000). Cisplatin-based therapy: A neurological and neuropsychological review. Psycho-Oncology, 9 (1), 29-39. doi: 10.1002/(SICI)1099-1611(200001/02)9:13.0.CO;2-Z

Cisplatin-based therapy: A neurological and neuropsychological review

1998

Journal Article

Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20

Wyld, DK, Selby, P, Perren, TJ, Jonas, SK, Allen-Mersh, TG, Wheeldon, J and Burchill, SA (1998). Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. International Journal of Cancer, 79 (3), 288-293. doi: 10.1002/(SICI)1097-0215(19980619)79:33.3.CO;2-2

Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20

1998

Journal Article

Endocrine aspects of the clinical management of breast cancer - Current issues

Wyld, DK, Chester, JD and Perren, TJ (1998). Endocrine aspects of the clinical management of breast cancer - Current issues. Endocrine-Related Cancer, 5 (2), 97-110. doi: 10.1677/erc.0.0050097

Endocrine aspects of the clinical management of breast cancer - Current issues